FIELD: medicine; pharmacology.
SUBSTANCE: group of inventions relates to medicine, pharmacology, pharmaceutics and psychiatry. Pharmaceutical composition having a selective antagonistic action against a dopamine D4 receptor and a serotonin 5HT2A receptor, for the treatment of a state of impulsivity, including gambling, and containing a compound of formula (I) wherein R1 is halogen, R2 is H or C1-C3-alkyl, or a pharmaceutically acceptable salt, hydrate or solvate thereof in an amount of from 10 mg to 800 mg and at least one pharmaceutically acceptable carrier; its application for the treatment of impulsivity, including gambling, and an appropriate way to treat impulsivity, including gambling. 
.
EFFECT: technical result consists in implementing the above application.
20 cl, 9 dwg, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF 7-FLUORO-8-CHLORO-5H-DIBENZO [B, E] [1, 4] DIAZEPINE AND THEIR APPLICATION | 2014 |
|
RU2610169C2 |
| THE SELECTIVE INVERSE AGONISTS OF SEROTONIN RECEPTORS AS MEDICATION TO CURE DISEASES | 2005 |
|
RU2442607C2 |
| AGENT FOR TREATMENT OF SCHIZOPHRENIA ON BASIS OF HYDROGENATED PYDIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND METHOD OF ITS APPLICATION | 2006 |
|
RU2338537C2 |
| THERAPEUTIC AGENTS | 2008 |
|
RU2468025C2 |
| SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS, USED AS THERAPEUTICS FOR NEURODEGENERATIVES DISEASES | 2004 |
|
RU2332401C2 |
| ORGANIC COMPOUNDS | 2018 |
|
RU2777366C2 |
| LIGAND WITH WIDE RANGE OF SIMULTANEOUS RECEPTOR ACTIVITY, PHARMACEUTICAL COMPOSITION, METHOD OF PREPARING SAID COMPOSITION AND MEDICINAL AGENT | 2008 |
|
RU2374245C1 |
| SELECTIVE INVERSE SEROTONIN 2A/2C RECEPTOR AGONISTS APPLICABLES AS THERAPEUTIC AGENTS FOR NEURODEGENERATIVE DISORDERS | 2008 |
|
RU2465267C2 |
| ORGANIC COMPOUNDS | 2018 |
|
RU2780002C2 |
| METHOD FOR PRODUCTION OF CLOZAPINE PHARMACEUTICAL COMPOSITION IN FORM OF TABLETS AND PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2441651C1 |
